Argos Therapeutics' Grant

Argos Therapeutics raised a round of funding on February 24, 2005. Investors include The Alliance for Lupus Research.

Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…

Articles about Argos Therapeutics' Grant: